Sarepta details Elevidys launch progress while awaiting key FDA decision on label expansion zbecker Thu, 02/29/2024 – 15:09 More: Sarepta details Elevidys launch progress while awaiting key FDA decision on label expansion Source: fierce
read moreEndo agrees to $465M bankruptcy deal with federal government, inks 2 opioid settlements esagonowsky Thu, 02/29/2024 – 13:47 More: Endo agrees to 5M bankruptcy deal with federal government, inks 2 opioid settlements Source: fierce
read moreArgenx goes again, ramping up unbranded campaign ahead of hoped-for label expansion ntaylor Thu, 02/29/2024 – 11:51 More: Argenx goes again, ramping up unbranded campaign ahead of hoped-for label expansion Source: fierce
read moreWith J&J settlement, Biocon Biologics gets a license to challenge Stelara in the US esagonowsky Thu, 02/29/2024 – 11:28 More: With J&J settlement, Biocon Biologics gets a license to challenge Stelara in the US Source: fierce
read moreAfter setting out on its own, Sandoz inks $265M deal to resolve ‘legacy’ price-fixing lawsuit fkansteiner Thu, 02/29/2024 – 10:27 More: After setting out on its own, Sandoz inks 5M deal to resolve 'legacy' price-fixing lawsuit Source: fierce
read moreApproximately 80% of patients taking Remicade from diagnosis had symptoms controlled More: ‘Top-down’ treatment strategy dramatically improves outcomes for Crohn’s patients Source: News
read more© 1994 - 2024 B.M. Pharmaceuticals